Freya Biosciences

Biotechnology
Data updated Nov 20, 2026Full reportReport a mistake

Facts

as of Nov 20, 2026

Driving immune-mediated therapeutic innovation for women. Freya focuses on the underlying drivers of disease, not just symptoms.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

Products

Products →

Freya Biosciences has 5 clinical trials on record, 2 under way.

Clinical trials
Effect of FB301 on Vaginal Bacterial Profile in Women With Asymptomatic Vaginal Dysbiosis Undergoing a Mock Frozen Embr…
phase 2 · under way · 30 participants · Vaginal Dysbiosis
Jul 2026
Chlorhexidine and/or Metronidazole Plus FB301 Pre-treatment Trial
phase 2 · under way · 120 participants · Bacterial Vaginosis (BV)
Mar 2026
FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (Dyscover-3)
completed · 97 participants · Vaginal Flora Imbalance
May 2023
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices